Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
FILANA THERAPEUTICS, INC. has filed 1,212 SEC EDGAR filings since 14 Mar 2000

SEC filing history

Showing 51-75 of 785 matching filings.

Per page
25
Current page
3
ARS File 001-41905

ARS

Filing date
14 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41905

FORM DEF 14A

Filing date
14 Apr 2025
Reporting date
23 May 2025
Next action
Verify source filing
PRE 14A File 001-41905

FORM PRE 14A

Filing date
03 Apr 2025
Reporting date
23 May 2025
Next action
Verify source filing
4

FORM 4

Filing date
03 Dec 2024
Reporting date
29 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Dec 2024
Reporting date
29 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41905

144 filing

Filing date
02 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41905

144 filing

Filing date
29 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-59335

SCHEDULE 13G/A filing

Filing date
26 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59335

SCHEDULE 13G/A

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Oct 2024
Reporting date
01 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .